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The central purpose of pulmonary rehabilitation is to reduce morbidity by improving functional
capacity through exercise. It is still unknown if improvements in functional capacity are main-
tained in the long-term and if this leads to increased physical activity levels as measured by
a free-living activity monitor. The hypothesis of this study was that pulmonary rehabilitation
would lead to a sustained increase in standard outcome measures and in daily physical activity.
Methods: A prospective study of 47 subjects with COPD was performed, registered at Clinical-
Trials.gov (Clinical Trial Number NCT 0112943). The primary outcome was a maintained
improvement in standard outcome measures with a secondary aim of an increase in daily phys-
ical activity. A convenient sample of the cohort (nZ 17) was re-evaluated at a third time point
at 1 year.
Results: A seven week hospital based outpatient pulmonary rehabilitation program led to
a significant reduction in total energy expenditure (p < 0.044) and breathlessness (Borg,
p < 0.011) and improved exercise capacity (ISWT, p > 0.001, 6MWT, p > 0.002) PiMax
(p > 0.007) and quality of life scores (SGRQ, p > 0.001, EQ5D, 0.025). However, pulmonary
rehabilitation did not significantly change the average number of daily steps taken, time spent
sedentary activity, METs consumed or daily physical activity. Indeed, all of the standard and
freeliving values had returned towards the baseline value at 1 year.ding, Beaumont Hospital, Dublin 9, Ireland. Tel.: þ353 1 8093762.
R.W. Costello).
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1672 C. Egan et al.Discussion: These findings show that while pulmonary rehabilitation increased exercise
capacity this was not transmitted into increased daily physical activity. Hence, alternative
methods to alter/affect behavioural change need to be addressed.
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In 2011, the World Health Organisation estimated that 31%
of the world’s population was inactive and that this physical
inactivity was the fourth leading risk factor for all global
deaths.1 In patients with Chronic Obstructive Pulmonary
Disease (COPD), activity levels are low compared to healthy
controls and other chronic conditions such as arthritis and
diabetes2,3 and decrease according to the clinical stage of
the disease and age4-7. Conversely, the more physically
active a person with COPD is the better their functional
status in terms of exercise capacity.8 Deconditioning as
a result of low levels of activities is detrimental to the
health of this already compromised patient population.9
The primary goal of pulmonary rehabilitation (PR) pro-
grammes has been to break the cycle of breathlessness and
deconditioning through prescribed exercise. The exercise
training component of PR significantly improves functional
capacity, quality of life, and symptoms of dyspnoea, even
for those patients in the moderate to severe category,10,11
and this is now considered to be an essential aspect of
treatment of patients with COPD. Short-term programmes
have shown immediate benefit and some have arrested
deterioration over time.12 However, a dose-effect response
has been suggested for long-term benefits.13e16
Physical inactivity and COPD are a product of lifestyle
choice and lack of knowledge. Combined these lead to
skeletal muscle abnormalities, deconditioning and loss of
function17,18 this loss of function is especially evident during
an exacerbation.19 Physical inactivity has been highlighted
as component in a global strategy that can be targeted to
help reduce the global burden of non-communicate
diseases.20 The evidence that increased physical activity is
achieved through participation in a pulmonary rehabilitation
are inconclusive but suggest that these two goals are too
incongruent for the present programme design.21,22 A two
tiered approach with functional capacity for secondary care
and physical activity for primary care may be the way
forward with both embracing the educational component
and creating a supportive environment, imparting knowl-
edge to the patient on the nature of the condition, teaching
coping mechanisms and by providing the patient with useful
tools by the way of ‘Action Plans’.23
Physical activity monitors are a useful tool for measuring
activity levels in the community. They are an objective,
accurate, non-invasive, and effective way of measuring
free-living activities.5,6,24 One such performance-based
motion sensor is the SenseWear accelerometer. The
SenseWear has previously been used in patients with COPD
and has been shown to be a reliable measure of physical
activity in this population.25 To-date, only a six month
programme has been shown to improve free-living activities
as measured by activity monitors.26 Given the paucity of
long-term follow up free-living physical activity outcomesfollowing standard PR programmes, further examination of
lasting effect is warranted. The hypothesis of this study was
that pulmonary rehabilitation leads to short term and sus-
tained improvement in functional capacity along with free-
living physical activity in patients with COPD in the setting
of a standard 7 week pulmonary rehabilitation program.
Methods
Study design
This two-phased longitudinal study followed a group of
patients with COPD (n Z 47) from baseline before pulmo-
nary rehabilitation, immediately after completion and at
three months, to examine the short term effects on stan-
dard measures and free-living physical activity. A conve-
nient sample of 17 of these subjects were re-recruited for
a follow up at 1 year, to evaluate if any sustained changes
occurred (Fig. 1). Exacerbations were reviewed at 1year
pre and 1yr post rehabilitation.
Criteria for selection of subjects was as recommended in
theGOLDGuidelines for pulmonary rehabilitation27 (Table 1).
All consecutive patients referred for pulmonary rehabilita-
tion over a ninemonth periodwereenrolled in the study after
informed consent was obtained. The study was approved by
the Beaumont Hospital Ethics committee, reference number
07/10. Some of these subjects also participated in a second
study per Ethical approval (07/48.) The primary outcomewas
to determine if participation in a supervised, outpatient
hospital based, seven-week pulmonary rehabilitation pro-
gramme resulted in sustained improvements in functional
capacity and altered free-living activities including percent
of time spent in sedentary activity, total TEE, physical
activity duration (PAD), percentage of 450MET-Minutes
a week (using 3METS as moderate activity,6 and the average
daily number of steps, sleep efficiency (SE) and sleep time
(ST) measured over 5 days. Secondary outcome measures
were measures of lung function, quality of life, and the
number of exacerbations for oneyearprior to PRandoneyear
post PR. The trialwas registered at ClinicalTrials.gov (Clinical
Trial Number NCT 01530412).
Intervention
Patients completed fourteen rehabilitation classes over
a seven week period on an outpatient basis.
Pulmonary rehabilitation
Pulmonary rehabilitation was held twice a week for seven
weeks with a recommended three further days of 30 min of
moderate intensity of activity. The first hour consisted of
a warm-up and cool-down component made up of balance
andflexibility exercises, alongwith an individually prescribed
Figure 1 CONSORT 2011 flow diagram.
Short term and long term effects of pulmonary rehabilitation 1673progressive exercise circuit. Ten exercises were chosen to be
specific to activities of daily living and consisted of cardio-
vascular exercise using an exercise bike and endurance/
strength training using light dumbbells and body resistance.
The progression and intensity of the exercise programmewas
made in terms of time andwas guided by themBORG score for
each exercise; for example, cardiovascular training using theTable 1 Inclusion/exclusion criteria.
Inclusion criteria
A diagnosis of COPD based on the GOLD staging of
the disease
Referred to pulmonary rehabilitation by a respiratory
consultant or senior team members or member of
the COPD Outreach Team
Modified medical research council score of 2 or above
Ability to mobilize independently
Motivated to exercise independentlymBORG score reported at 60% and 80% of max in the Incre-
mental Shuttle Walk Test (ISWT) was used28e30 and for
endurance/strength training the prescription of intensitywas
based on target dyspnoea ratings between moderate (3) and
severe (5) [50% V02peak (functional aerobic
capacity)Z dyspnoea rating of 3 of the mBORG score]. The
second hour consisted of a multidisciplinary interactive
educational session based on international guidelines.10
Patients undertook a home inspiratory muscle training
(IMT) programme commencing at between 15% and 30% of
PiMax for 10e15 min a day, five days a week)31,32; This was
progressed weekly to a maximum of 60% of PiMax for 30 min
(or 2  15 min) five days a week, with an inspiratory/
expiratory ratio of 3:4 (8e9 breaths a minute). The
prescribed load was great enough to overload the inspira-
tory muscles without exhausting them. Patients were
advised to discontinue their IMT if they experienced an
exacerbation. The educational component consisted of
multidisciplinary talks in areas explaining the nature of
COPD, the role of cigarettes and importance of smoking
cessation, symptom recognition, inhaler use and technique,
pharmacology, coping strategies, action plans etc. Infor-
mation was also provided by way of two booklets one of
which was a copy of all talks given for future reference and
the other a ‘Beaumont Respiratory Passport’ (http://www.
beaumont.ie/files/2010/docs/20110610052029_passport.
pdf) which was developed by our own service and been
shown to reduce the number of exacerbations.33
Outcome measures
A demographic form captured the patient’s age, gender,
history of smoking, body mass index (BMI), modified Medical
Research Council dyspnoea score (mMRC)34 and the modi-
fied BORG Score at rest. Outcome measures included
measures of pulmonary function, and measures of free-
living activity.
Measurement of static pulmonary function
Forced expiratory volume in 1 s (FEV1), inspiratory vital
capacity (IVC) and forced vital capacity (FVC) were deter-
mined using a Micro Medical MicroLab spirometer.35
Maximum peak inspiratory pressure (PiMax) wasExclusion criteria
No evidence of COPD on spirometry
Acute exacerbation within the last 4e6 weeks
Evidence of ischemic heart disease/acute changes on ECG
Uncontrolled hypertension
Insulin dependent diabetes mellitus
Inability to exercise independently or
musculoskeletal/neurological conditions which would
prevent completion of the course
Lung cancer
Previous attendance at pulmonary rehabilitation.
1674 C. Egan et al.determined using a Micro Medical Respiratory Pressure
Meter. The best of five reproducible measurements with
a maximal variability of 10% was used.32
Measurement of free-living physical activity
The SenseWear Pro Armbands were used to measure phys-
ical activity (SenseWear Pro Armbands; BodyMedia, Inc
Pittsburgh, PA). This activity armband is a biaxial acceler-
ometer that records physiological parameters including
physical activity duration (PAD) (set at 3METs/minute for
moderate intensity as per Watz et al., 20096). To determine
time spend in moderate activity the percentage of MET/min
was calculated and for the purpose of this study, moderate
intensity of 3METS over 150 min per week was the equiva-
lent of 450MET/minutes per week.36 Total energy expen-
diture (TEE), metabolic equivalent (METs), steps per day,
and sleep time (ST)/efficiency (SE) were also measured.
The validated SenseWear activity monitor was worn over
the right triceps for five consecutive days for approximately
23 h a day by all groups5 as armbands were removed for
bathing. Patients were provided with written instructions
for care. Data collected were downloaded using the soft-
ware (INNERVIEW professional version 6.0.0; BodyMedia,
Pittsburgh, PA). METs were set as follows 0e3 sedentary,
3e6 Moderate, 6 vigorous. In order to standardise physical
activity for each participant, only those data defined as
having collected 85% over the five days of prescribed time
were included for each time set (5days). The average sum
over the times was used for data analysis.
Measurement of exercise capacity
The Incremental Shuttle Walk test (ISWT) was performed in
accordancewith standard recommendations aswas the 6min
walk test (6MWT).37,38 Minimal clinical important difference
(MCID) for the 6MWT is 26m39 and the ISWT is 47.5m.40
Quality of life
Two quality of life measurements were recorded at each
time point: The St George’s Respiratory Questionnaire
(SGRQ) and the EuroQol (EQ-5D).41,42
Healthcare use
Pharmacy records from the year prior to the study and at the
completionof theyear followupwereobtained forall subjects
and a record of the number of antibiotics and steroid courses
administered for respiratory complaints were recorded. This
was interpreted as the number of exacerbations in that time
period, as defined by requiring a change in medication.Statistical analysis
Data on 47 patients were entered and analysed using SPSS
(PASW) version 18 for normal distribution using parametric
and non-parametric tests with a statistical difference
measured as a p-value of less than 0.05. The hypothesis that
a significant change would occur in PA following PR was
tested, where data were normally distributed, with
a repeated measures ANOVA with Bonferroni adjusted pair-
wise comparisons between (i) pre and post pulmonary
rehabilitation (week 0e7) and (ii) pre to short term follow
up (week 0 to week 20) for the total group. This was alsoperformed for the pre to 1 year follow up (week 0 to week
52) in a subset (n Z 17). For non-normal data, Friedman’s
test was used to compare median scores over the repeated
time points. Wilcoxon Sign Rank tests with Bonferroni
adjusted critical values were used for the pairwise
comparisons. It was not possible to power the study based on
armband data due to the large number of patients required;
therefore, this study should be taken in the context of being
investigative in a real clinical Irish hospital setting.
Results
Of the 60 subjects who fulfilled in the inclusion/exclusion
criteria, 47 were recruited for pulmonary rehabilitation and
45 received pulmonary rehabilitation; Data for 47 patients
were retained for intention to treat purposes. Thirteen
patients did not complete the course (w28% drop-out rate).
Four patients did not attend for follow-up at threemonths. A
convenient sample of 17 patients was re-assessed at 1 year.
Baseline characteristics
Baseline characteristics for patients at week 0, week 7 and
week 20 are presented in Table 2. Participants were older
adults who smoked approximately 340,000 cigarettes in
their lifetime. Slightly less than half were male with a mean
FEV1 indicating severe obstruction. Subjects generally had
an overweight BMI, a poor exercise performance, and
weakened inspiratory muscles at baseline. Moreover,
quality of life was impaired, in particular the SGRQ domains
‘Symptom’ and ‘Activity’. Subjects were sedentary,
spending only 9% in activities equal or above the recom-
mended 500MET/mins a day43 and only 36% of the 10,000
recommended steps a day. A 98% compliance rate was
recorded for wearing the armband over the averaged
recorded 5 days. Table 3 gives a breakdown of 17 patients
who were contacted at one year for reassessment.
Short term effects (Wk0-Wk7)
Short-term effects (N Z 30) (Table 2): Functional exercise
performance increased significantly immediately after the
7-week PR programme [Incremental Shuttle Walk test:
32.8  42.3m, p < 0.001; 6MWT: 37.1  51.6m, p < 0.002]
as well as inspiratory muscle strength [PiMax: 9.2  13.4
cmH2O, p < 0.007]. There was a significant fall (improve-
ment) in symptoms of breathlessness [mBorg score
(0.6  1.5, pZ 0.011) and in health-related quality of life
[SGRQ total score: 8.1  10.6 points, p < 0.001; the EQ5D
(p < 0.025)]. There was a significant decrease in TEE
(143  273 kcal, p Z 0.016). There was no change in the
average number of daily steps, time spent sedentary or
time spent in active exercise at either time point after
rehabilitation compared to the baseline values.
Medium term effects (Wk 0eWk 20)
Medium term effects (NZ 30) (Table 2): PiMax was the only
variable to maintain a significant difference at the
Wk0eWk20 (p Z 0.003). All other variable appeared to
Table 2 Profile of patient scores over time.
Measure Week 0 Pts Week 7 Pts Week 20 Pts Significance
difference
between 3 time
points
Pair wise
comparisons
1. Wk0eWk7
2. Wk0eWk20
BMI 27.5  6.2 47 27.4  6 34 27.7  6 30
FEV1% 46.8  16.6 46 46.8  16.9 32 51.6  17.2 28
FVC % 78.8  20.8 45 78.1  20.5 32 83.4  20.1 27
IVC% 72.4  21.7 47 74.3  25.7 33 77.8  15.2 29
PiMax 70.0  31.2y 47 77.9  27.2 y 33 80.9  30.1y 30 p Z 0.001 1 Z 0.007
2 Z 0.003
ISWT 225.4  107.8 y 47 260  120.8y 34 249.3  105.3 30 p Z 0.013 1 Z 0.001
6MWT 355.5  89.4y 47 399.9  100.6y 33 384.5  88.8 30 p Z 0.001 1 Z 0.002
BORG 0.7  1.2 * 47 0.2  0.8 ** 34 0.3  0.7 30 p Z 0.001 1 Z 0.011
mMRC 2.3  1.0* 47 1.8  1 34 2.1  0.8 30 p Z 0.035
SGRQ 56.1  13.7 y 47 47  14.6y 34 51.4  17 30 p Z 0.003 1 Z 0.001
Symptom 69.2  17.2 47 66.9  19.6 34 67  19.6 30
Activity 66.5  17.8 47 59  22.7 34 61.1  18.7 30
Impact 46.6  17.8 y 47 36.2  15.8 34 40.6  21.5 30 p Z 0.007
EQ5D 0.7  0.3 47 0.8  0.1 ** 34 0.8  0.2 29 1 Z 0.025
TEE 1951  471y 46 1860  420 y 30 1953  485 22 p Z 0.016 1 Z 0.044
AEE 255.6  401 46 208.2  231.8 30 226.6  312.3 22
PAD 48.0  66.8 46 51.0  53.0 30 47.6  63.5 22
% of 450
MET/Min
74.1  104.2 46 79.3  82.4 30 74.2  98.8 22
METs 1.2  0.3 46 1.2  0.3 30 1.1  0.3 22
Step 3611  2863 46 3527  2870 30 3242  3436 22
SE 76.3  10.0 46 78.8  8.3 30 77.1  8.1 22
ST 392.0  102.4 46 400.7  75.8 30 391.7  123.0 22
%Time Sed
Mode
93.6  7.8 46 93.5  4.1 30 91.8  7.3 22
% Compliance 93.4  7.9 46 93.5  4.1 30 91.8  7.3 22
Parametric yZ 0.05; Nonparametric *pZ 0.05 and **pZ <0.025 (Bonferroni correction for 2 comparisons). BMI; body mass index, FC;
functional capacity, SWT; shuttle walk test, mMRC; modified medical council research score, SGRQ; St George’s respiratory question-
naire, EQ5D; EuroQuol questionnaire, TEE; total energy expenditure, AEE; active energy expenditure, PAD; physical activity duration in
minutes, SE; sleep efficiency, ST; Sleeptime.
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rehabilitation, there was a significant change over the 3
time periods (Wk0eWk7eWk20) for the mMRC (p Z 0.035)
and the Impact component of the SGRQ (p Z 0.007).
Long term effects (Wk 0eWk 52)
Long Term effects (nZ 17) (Table 3): Between the four time
points (Wk0eWk7eWk20eWk52) no significant differencewas
found for lung function or physical activity levels. Significant
improvements between these four time points were seen in
the exercise field tests [ISWT (pZ 0.028), 6MWT (pZ 0.009)],
breathlessness at rest and activity [BORG (p Z 0.003) and
mMRC (pZ 0.008)] and in the Activity component of the SGRQ
(pZ 0.003).. There was no significant finding at Wk 52.
Healthcare consumption
Looking at exacerbation rate, upon receiving additional
ethical approval and consent, retrospective data wasobtained on those who completed the programme pre and
post rehabilitation (total nZ 22; MZ 11). The average age
was 67.3 (7.1), the average smoke pack year history was
38.1 (27.5), There was an average FEV1% of 49.6 (17.4).
In total prior to rehabilitation 22 subjects filled 116
prescriptions for antibiotics and 49 prescriptions for
steroids. The average number of antibiotics was 5 (4) and
steroids 2 (2). One year on these same patients filled 131
prescriptions for antibiotics and 64 prescriptions for
steroids. The average number of antibiotic was 6 (4) (an
increase of 20%) and steroids 3(3) (an increase of 50%).
Exacerbation rates during the class were not captured.
Discussion
The results of this study show that after a seven week
pulmonary rehabilitation programme there were significant
improvements in exercise field tests (ISWT and 6MWT),
breathlessness scores both at rest (mBORG), inspiratory
muscle strength (PiMax) and quality of life scores,
Table 3 Long-term analysis on 17 patients.
Measure Week 0 Week 7 Wk 20 Week 52 Significance
difference
between 4 time
points
Pair wise
comparisons
1.Wk0eWk7
2.Wk0eWk52
BMI 26.6  6.3 26.3  5.8 26.8  5.9 26.9  6.4
FEV1% 53.6  16.7 53.4  17.6 55.9  17.4 54.3  17.5
FVC % 86.9  17.1 87.1  19.2 90.2  19 90.9  21.8
IVC% 84.5  81.9 82.5  31 81.8  12.6 80.9  17.5
PiMax 77.5  31.6 82.8  30.4 85.7  31.8 72.5  21.1
ISWT 268.5  125.9 y 314.4  123.6y 282.9  98.22 256.3  118.5 p Z 0.028 1 Z 0.001
6MWT 391.2  90 y 444.9  78.6 y 408.6  73 376.8  103.9 p Z 0.009 1 Z 0.03
BORG 0.85  1.3 * 0.0  0.0 ** 0.4  0.7 0.3  0.6 p Z 0.003 1 Z 0.011
mMRC 1.9  1.1* 1.3  0.9 1.9  0.8 2.3  0.9 p Z 0.008
SGRQ 51.5  16.3 41.0  14.9 y 46.7  15.7 50  20.6 1 Z 0.012
Symptom 65.7  20.9 59.6  23.4 61.4  21.6 60.7  19.1
Activity 62.2  22.3 y 49.31  24.4 57.4  20.1 68.8  15.6 p Z 0.003
Impact 42.5  20 33.06  17.1 34.8  19.5 39.2  20.8
EQ5D 0.77  0.1 0.82  0.1 0.79  0.2 0.8  0.1
TEE 1917  500.1 1722  364.8 1880  431.1 2123  871
AEE 270.0  431.9 197.4  167.9 248.8  359.3 476.8  736
PAD 62.2  97.8 60.5  54.5 56.3  75.4 78.9  112.2
METs 1.2  0.3 1.3  0.3 1.2  0.3 1.2  0.3
Step 3702  2770 3598  2039 3179  2703 3083  1938
SE 76.4  9.6 79.5  8.7 77.1  6.8 78  11.8
ST 414.4  72.3 400.8  85.3 410.8  63.9 393.1  80
%Time
Sed Mode
93.3  7.4 93  4.6 90.3  9.3 91.9  8.7
Parametric y Z 0.05; Nonparametric *p Z 0.05 and **p Z <0.025 (Bonferroni correction for 2 comparisons) BMI; body mass index, FC;
functional capacity, SWT; shuttle walk test, mMRC; modified medical council research score, SGRQ; St George’s respiratory question-
naire, EQ5D; EuroQuol questionnaire, TEE; total energy expenditure, AEE; active energy expenditure, PAD; physical activity duration in
minutes, SE; sleep efficiency, ST; Sleep time.
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care utilisation scores (EQ-5D) also improved significantly.
This indicates that a seven week pulmonary rehabilitation
programme has clear benefits on physical fitness and
subjective well-being in patients with severe COPD. There
were no changes in measures of free-living activity other
than a reduction in total energy expenditure immediately
post rehabilitation. Twenty weeks after the programme
started those factors which had improved started to
decline, with improvements in PiMax being the only
measures to maintain a significant improvement at 20
weeks. In the 1 year follow-up, none of the improvements
were sustained in a sub-set of patients. There was evidence
of an increase in antibiotic and steroid use as judged by
difference in the number of antibiotic and steroid
prescriptions filled in the year prior to and the year after
the study. Hence, the standard PR programme used in many
centres and recommended by best-practice guidelines ful-
fils the short-term goal of breaking the cycle of breath-
lessness and deconditioning and in teaching self
management skills but may not lead to long-term benefits.
People with COPD underestimate the time spent in
sedentary mode. This was well demonstrated by Pitta et al.
(2005) whose work highlighted the disparities between self
reported activity levels and actual physical activity levels inpatients with COPD when comparing questionnaires with
video and motion sensors (DynaPort Activity Monitor). The
patient significantly underestimated the time in sitting
(p < 0.001) when compared to time doing other activities
and overestimated the time spent in walking (p Z 0.04).44
Building upon this knowledge the present paper reinforces
the disconnect between what the patient thinks they do,
and what they can do regardless of fitness level, i.e. an
increase in exercise endurance does not transmit into an
increase in activity at home as judged by measures of
average daily number of steps with an accelerometer. This
finding is supported by Walker et al. (2008)45 who found no
predictive value in an increase in functional capacity when
it came to change in activity; rather, it was baseline FEV1
that predicted improvements in free-living activities. Using
the Physical Activity Recall Questionnaire, Soicher et al.
(2012)46 studied the long-term effects of a 3-month PR
programme on activity levels. They reported that only 36%
of subjects met the minimal recommended 30 min of
exercise per day at 3 mths and 26% at 12 months with a 6%
dropout rate at 12 months. Past exercise habits, 6MWT and
barriers to exercise were identified as being significant to
distinguish between three distinct activity groups. Limiting
factors to completion of rehabilitation was not the goal of
the present study, however, the intensity of activity at
Short term and long term effects of pulmonary rehabilitation 1677home was clearly not increased in those reassessed at one
year in a group of 17 patients with an average FEV1pred 
50%: i.e. baseline physical activity duration (PAD) at 3 METs
was consistent wk0 (45%), wk20 (41%) and wk52 (44%).
Overall, the current study adds to a literature, most
studies present non-significant data on activity promotion,
as reviewed by Casaburi and Ng.21,22
One possible explanation for a decrease in energy
expenditure after PR would be as a direct result of physi-
ological changes resulting in less effort required for the
same activity. A reduction in breathlessness may be as
a result of decreased effort and also perhaps through the
distraction from sensations of dyspnoea which occur during
exercise within a group or through the mood enhancing
effects of social interaction and exercise. We do not
believe that the results of this study represent a sample
error, firstly because there were improvements in the
parameters that normally reflect a successful PR, and
secondly, there was a marked consistency of the activity in
the three follow up periods. The accelerometer used in the
study has been widely used and validated in prospective
studies of patients with COPD.5,47,48 Similar protocols were
used in these prior studies, including an extended duration
of monitoring, avoiding holiday periods when social
behaviour is different and by avoiding seasonal variations.49
Only data that was consistent with 85% of time worn were
included to exclude bias from inconsistent wearing of the
device, which may underestimate activity. Hence, while we
only have one technique of identifying free-living activity
the technology is robust and reproducible.
The St.George’s Respiratory questionnaire41 is a disease
specific questionnaire with three domains(Symptom,
Activity and Impact) combining to give an overall QoL score.
In the present study a significant improvement in the
composite score was identified pre and post rehabiliation
along with a significant change in the Impact component
over a 3month period. Clinically relevant was that the
common effect size exceeded the minimal clinical impor-
tant difference (4) in both the Impact and Activity
components pre and post rehabilitation. These results are
consistent with the findings from a systematic review
undertaken by Puhan50 who showed that Impact followed
by Activity components improved over Symptoms after
a course of pulmonary rehabilitation. These two compo-
nents could go some way to explain the increase in func-
tional capacity and decreased effort (TEE) during daily
activities in our small cohort of patients. The duration of
the class (7Wks) and small number of patients may be
limiting factors to larger improvements; however, were
enough to affect the cost of care as demonstrated by the
improved Utility Score in the EuroQol.
The breathlessness on activity scale (mMRC) did not
demonstrate an immediate effect post rehabilitationwhich is
consistent with the Activity Component of the SGRQ. Again
the short duration of class and small numbers may have
contributed to this finding. Also due to the absence of
a treadmill or walking track, the specificity of the training
may have been insufficient to meet the patients’ needs. This
has since been addressed. In a separate study we have
demonstrated an improvement in this domain immediately
post rehabilitationwith theadditionof acupuncture in a small
cohort of patients when compared to rehabilitation alone.The combination of exercise, education and self-
management strategies are the cornerstone of the success
of pulmonary rehabilitation although the mechanisms
involved in this improvement are still poorly under-
stood.51,52 The indications are that while patients obtain
benefits in functional capacity compared to no interven-
tion53 this is not sustained and does not carry over to their
home life. Maintaining benefits after PR has proven to be
a difficult undertaking and this study shows that without
intervention benefits fade at 3months. Other studies that
have included strategies that include bimonthly phone calls
to subjects did not prevent people from returning to their
old behaviour patterns.46 Identifying barriers and previous
exercise behaviour patterns may be key to successfully
increasing activity and functional levels in the long term
but any improvement may be limited to a subgroup of
patients with better lung function and decreased exacer-
bations rates.26,46 As evident by this study it would be
erroneous to translate measures of physical activity into
estimates of physical fitness, capacity or actual function.
Physical activity levels should instead be viewed in the
context of lifestyle choice and behaviour patterns in order
to affect change.
It is possible that the study was underpowered, and the
subject number was small. Nonetheless, the standard
measures of improvement seen in a clinical evaluation of
pulmonary rehabilitation were evident. It has been previ-
ously demonstrated that a six month programme is required
to alter patients freeliving activity levels26; therefore, the
additional goal for pulmonary rehabilitation to increase
activity levels maybe unrealistic in their present format. A
further limitation of the study is that the accelerometer
does not inform as to possible changes in the subjects
ability to undertake their activities of daily living. Activities
of daily (ADL) living were not measured therefore it is not
possible to correlate ADLs with free-living activities or the
other functional measures that improved.
Conclusion
In summary a traditional 7 week pulmonary rehabilitation
programme increased physical capacity which in itself is
very worthwhile; however, these benefits were not sus-
tained after one year. There was no increase in free-living
activity.Abbreviations
6MWT six minute walk test
ADL activity of daily living
BMI body mass index
COPD chronic obstructive pulmonary disease
EQ5D EuroQol
FEV1 forced expiratory pressure in 1 s
FVC forced vital capacity
ISWT incremental shuttle walk test
IVC inspiratory vital capacity
mBORG modified BORG
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METs metabolic equivalent
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SE sleep efficiency
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